World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
55
Citations
10428
World Ranking
3833
National Ranking
1500

John P. DeVincenzo publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where John P. DeVincenzo sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 141 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

John P. DeVincenzo D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where John P. DeVincenzo sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 55 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

John P. DeVincenzo is affiliated with Middle Tennessee State University in the United States. Their research primarily revolves around the field of Medicine, with a focus on epidemiology, infectious diseases, pulmonary and respiratory medicine, pediatrics, perinatology, child health, and surgery.

The scientist's main research topics include:

  • Respiratory viral infections research
  • Neonatal respiratory health research
  • Congenital diaphragmatic hernia studies
  • Pneumonia and respiratory infections
  • Viral gastroenteritis research and epidemiology
  • Neonatal and fetal brain pathology
  • Fetal and pediatric neurological disorders

They have contributed to multiple peer-reviewed papers. Some of their recent publications include:

  • "Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants," 2020, New England Journal of Medicine
  • "Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study," 2021, The Journal of Infectious Diseases
  • "Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine," 2023, Science Translational Medicine
  • "Altered gut microbiota in infants is associated with respiratory syncytial virus disease severity," 2020, BMC Microbiology
  • "Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study," 2020, The Journal of Infectious Diseases

Frequent co-authors collaborating with John P. DeVincenzo include:

  • Stephania A. Cormier
  • Mahdieh Shabanian
  • David Siefker
  • Luan D. Vu
  • Dahui You

The scientist has published multiple times in key venues such as:

  • The Journal of Infectious Diseases
  • arXiv (Cornell University)
  • The Journal of Immunology
  • Influenza and Other Respiratory Viruses
  • Research Square (Research Square)

Best Publications

  • Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.

    M. Pamela Griffin;Yuan Yuan;Therese Takas;Joseph B. Domachowske

  • A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

    John DeVincenzo;Robert Lambkin-Williams;Tom Wilkinson;Jeffrey Cehelsky

  • Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.

    Vasanthi Avadhanula;Carina A. Rodriguez;John P. DeVincenzo;Yan Wang

  • Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus

    John P. DeVincenzo;Tom Wilkinson;Akshay Vaishnaw;Jeff Cehelsky

  • Oral GS-5806 activity in a respiratory syncytial virus challenge study

    John P DeVincenzo;Richard J Whitley;Richard L Mackman;Cecilia Scaglioni-Weinlich

  • Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)

    John DeVincenzo;Jeffrey E Cehelsky;Rene Alvarez;Sayda Elbashir

  • Respiratory syncytial virus load predicts disease severity in previously healthy infants.

    John P DeVincenzo;Chadi M El Saleeby;Chadi M El Saleeby;Andrew J Bush

  • Respiratory Syncytial Virus Load, Viral Dynamics, and Disease Severity in Previously Healthy Naturally Infected Children

    Chadi M. El Saleeby;Andy J. Bush;Lisa M. Harrison;Jody A. Aitken

  • Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.

    Maximillian S. Habibi;Agnieszka Jozwik;Spyridon Makris;Jake Dunning

  • Reduction of Respiratory Syncytial Virus (RSV) in Tracheal Aspirates in Intubated Infants by Use of Humanized Monoclonal Antibody to RSV F Protein

    Richard Malley;John DeVincenzo;Octavio Ramilo;Penelope H. Dennehy

  • Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

    John P DeVincenzo;Matthew W McClure;Julian A Symons;Hosnieh Fathi

  • RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus

    Martin R Zamora;Marie Budev;Mark Rolfe;Jens Gottlieb

  • SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans

    E Kaitlynn Allen;Adrienne G Randolph;Tushar Bhangale;Pranay Dogra

  • Mucosal Immune Responses Predict Clinical Outcomes during Influenza Infection Independently of Age and Viral Load

    Christine M. Oshansky;Andrew J. Gartland;Sook-San Wong;Trushar Jeevan

  • Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants

    Steven C. Buckingham;Andrew J. Bush;John P. Devincenzo

  • RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy

    Rene Alvarez;Sayda Elbashir;Todd Borland;Ivanka Toudjarska

  • Respiratory Syncytial Virus Disease Is Mediated by Age-Variable IL-33.

    Jordy Saravia;Dahui You;Dahui You;Bishwas Shrestha;Bishwas Shrestha;Sridhar Jaligama;Sridhar Jaligama

  • ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients.

    Unknown

  • Comparison of a Real-Time Reverse Transcriptase PCR Assay and a Culture Technique for Quantitative Assessment of Viral Load in Children Naturally Infected with Respiratory Syncytial Virus

    Stephanie M. Perkins;David L. Webb;Shauna A. Torrance;Chadi El Saleeby;Chadi El Saleeby

  • Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age

    Chadi M. El Saleeby;Grant W. Somes;John P. DeVincenzo;Aditya H. Gaur

  • A randomized, double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection : effects on RSV quantity and clinical outcome

    Steven C. Buckingham;Hasan S. Jafri;Andrew J. Bush;Cecilia M. Carubelli

Frequent Co-Authors

Octavio Ramilo
Octavio Ramilo St. Jude Children's Research Hospital
Paul G. Thomas
Paul G. Thomas St. Jude Children's Research Hospital
Yonatan H. Grad
Yonatan H. Grad Harvard University
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Eric A. F. Simões
Eric A. F. Simões University of Colorado Denver
Richard J. Webby
Richard J. Webby St. Jude Children's Research Hospital
Joseph B. Domachowske
Joseph B. Domachowske SUNY Upstate Medical University
Richard Malley
Richard Malley Boston Children's Hospital
Edward E. Walsh
Edward E. Walsh University of Rochester Medical Center
William C. Gruber
William C. Gruber Pfizer (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open diverse career opportunities. Many programs focus on healthcare and biological sciences, fields that often welcome graduates with a background in microbiology.

Those with unique challenges, such as a criminal record, may find guidance in options highlighted by college degrees for felons, showing how to pursue education and careers despite past setbacks.

Another relevant path is becoming a functional medicine NP, blending specialized medical knowledge with patient-centered care, which can complement a microbiology foundation.

For those interested in healthcare administration, obtaining certifications like a CPC credential helps advance careers in medical coding, an essential aspect of managing health information.

Similarly, a career in health information management offers promising opportunities, with insights available about health information management salary entry-level and potential growth.

Exploring these online degrees and career pathways can provide microbiology students with versatile options beyond the lab, addressing demand in healthcare, data management, and patient care sectors.

Best Scientists Citing John P. DeVincenzo

Trending Scientists

Recently Published Articles